Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …

Persistent, low‐grade inflammation is now considered a hallmark feature of chronic kidney
disease (CKD), being involved in the development of all‐cause mortality of these patients …

Dysbiosis represents changes in composition and structure of the gut microbiome
community (microbiome), which may dictate the physiological phenotype (health or …

Chronic kidney disease (CKD) affects> 10% of the adult population. Each year,
approximately 120,000 Americans develop end-stage kidney disease and initiate dialysis …

The gastrointestinal (GI) microbiome of cats and dogs is increasingly recognized as a
metabolically active organ inextricably linked to pet health. Food serves as a substrate for …

Background: Targeting the gut microbiota may become a new therapeutic to prevent and
delay the progression of chronic kidney disease (CKD). Nonetheless, the causal relationship …

Chronic Kidney Disease (CKD) is a debilitating disease associated with several secondary
complications that increase comorbidity and mortality. In patients with CKD, there is a …

Traditional dietary recommendations to renal patients limited the intake of fruits and
vegetables because of their high potassium content. However, this paradigm is rapidly …

Uremic toxins, such as indoxyl sulfate (IS) and p-cresol, or p-cresyl sulfate (PCS), are
markedly accumulated in the organs of chronic kidney disease (CKD) patients. These toxins …

Abstract Background Trimethylamine N-oxide (TMAO) is a metabolite that has attracted
attention due to its positive association with several chronic non-communicable diseases …